Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cresco Labs (CRLBF) EPS (Weighted Average and Diluted) (2020 - 2023)

Cresco Labs filings provide 3 years of EPS (Weighted Average and Diluted) readings, the most recent being $0.01 for Q4 2023.

  • On a quarterly basis, EPS (Weighted Average and Diluted) changed N/A to $0.01 in Q4 2023 year-over-year; TTM through Dec 2023 was $0.01, a N/A change, with the full-year FY2025 number at -$0.38, down 72.73% from a year prior.
  • EPS (Weighted Average and Diluted) hit $0.01 in Q4 2023 for Cresco Labs, down from $227432.8 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $227432.8 in Q3 2021 to a low of $0.01 in Q4 2023.
  • Median EPS (Weighted Average and Diluted) over the past 3 years was $68195.7 (2020), compared with a mean of $98542.8.
  • The widest YoY moves for EPS (Weighted Average and Diluted): up 233.5% in 2021, down 233.5% in 2021.
  • Cresco Labs' EPS (Weighted Average and Diluted) stood at $68195.7 in 2020, then soared by 233.5% to $227432.8 in 2021, then tumbled by 100.0% to $0.01 in 2023.
  • The last three reported values for EPS (Weighted Average and Diluted) were $0.01 (Q4 2023), $227432.8 (Q3 2021), and $68195.7 (Q3 2020) per Business Quant data.